Genesys Capital joins $120 mln Series F financing of Invitae
San Francisco-based genetic information company Invitae Corp has secured US$120 million in a Series F financing round. New investors in the company included The Broe Group, Decheng Capital, Deerfield Management, OrbiMed, Perceptive Advisors, Rock Springs Capital and Wellington Management. They were joined by existing investors, including Canadian venture capital firm Genesys Capital and U.S. firm Thomas McNerney & Partners. Invitae, which was founded in 2010, said it would use proceeds of the deal to accelerate the build out of its infrastructure for its genetic information business, and to expand its global market presence.
14 October 2014•2 mins read
